News & Press Releases
Filter by:
Mintz Prevails Over SEC in Rare Motion to Dismiss Victory
September 03, 2022
Mintz Takes Lead For Med-Pharmex In Its Sale To Britain’s Dechra
August 31, 2022
Mintz completed a deal as counsel to Med-Pharmex in its sale to British-owned veterinary products developer and manufacturer Dechra Pharmaceuticals. Through the sale, Dechra will gain further access and nearly 40 years of experience in the U.S. veterinary health market.
Mintz Advises Biolog-id in SPAC Transaction
August 29, 2022
Mintz is strengthening its two decades-long reputation for being at the forefront of SPAC transactions serving as Biolog-id's legal advisor in its agreement to become a publicly traded company via a business combination with Genesis Growth Tech Acquisition Corp.
